Joni L. Rutter: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{short description|Biography of Joni L. Rutter}} | |||
{{Use dmy dates|date=October 2023}} | |||
== Early Life and Education == | ==Early Life and Education== | ||
Rutter was born | [[File:Joni_L._Rutter.jpg|thumb|right|Joni L. Rutter]] | ||
Joni L. Rutter was born in the United States. She pursued her undergraduate studies in biology, where she developed a keen interest in genetics and molecular biology. Rutter continued her education by obtaining a Ph.D. in pharmacology, focusing on the genetic and environmental factors influencing drug response. | |||
== Career == | ==Career== | ||
Rutter began her career as a | Joni L. Rutter began her career as a researcher in the field of pharmacogenomics, which studies how genes affect a person's response to drugs. Her work has significantly contributed to the understanding of how genetic variations can influence drug efficacy and safety. | ||
===National Institutes of Health=== | |||
Rutter joined the [[National Institutes of Health]] (NIH), where she held various positions, including leadership roles in the [[National Institute on Drug Abuse]] (NIDA). At NIDA, she was instrumental in advancing research on the genetic basis of addiction and substance use disorders. | |||
In 2020, Rutter was appointed as the Director of | ===All of Us Research Program=== | ||
In 2020, Joni L. Rutter was appointed as the Director of the [[All of Us Research Program]], a historic effort to gather health data from one million or more people living in the United States. The program aims to accelerate research and improve health by taking into account individual differences in lifestyle, environment, and biology. | |||
== Research | ==Research Contributions== | ||
Rutter's research has | Rutter's research has focused on the intersection of genetics, environment, and health. She has published numerous studies on the genetic factors that contribute to addiction and the role of pharmacogenomics in personalized medicine. | ||
===Pharmacogenomics=== | |||
Her work in pharmacogenomics has helped pave the way for more personalized approaches to medicine, where treatments can be tailored to the genetic makeup of individual patients, thereby improving outcomes and reducing adverse effects. | |||
== | ===Addiction Genetics=== | ||
Rutter | Rutter has also been a leading figure in the study of addiction genetics, exploring how genetic predispositions can influence the risk of developing substance use disorders. Her research has provided insights into potential targets for therapeutic intervention. | ||
== | ==Awards and Honors== | ||
Throughout her career, Joni L. Rutter has received numerous awards and honors for her contributions to medical research and public health. Her work has been recognized by various scientific organizations and institutions. | |||
==Related pages== | |||
* [[Pharmacogenomics]] | |||
* [[National Institutes of Health]] | |||
* [[Addiction]] | |||
* [[Personalized medicine]] | |||
[[Category:American scientists]] | [[Category:American scientists]] | ||
[[Category:Women in science]] | [[Category:Women in science]] | ||
[[Category: | [[Category:Living people]] | ||
Latest revision as of 10:59, 15 February 2025
Biography of Joni L. Rutter
Early Life and Education[edit]
Joni L. Rutter was born in the United States. She pursued her undergraduate studies in biology, where she developed a keen interest in genetics and molecular biology. Rutter continued her education by obtaining a Ph.D. in pharmacology, focusing on the genetic and environmental factors influencing drug response.
Career[edit]
Joni L. Rutter began her career as a researcher in the field of pharmacogenomics, which studies how genes affect a person's response to drugs. Her work has significantly contributed to the understanding of how genetic variations can influence drug efficacy and safety.
National Institutes of Health[edit]
Rutter joined the National Institutes of Health (NIH), where she held various positions, including leadership roles in the National Institute on Drug Abuse (NIDA). At NIDA, she was instrumental in advancing research on the genetic basis of addiction and substance use disorders.
All of Us Research Program[edit]
In 2020, Joni L. Rutter was appointed as the Director of the All of Us Research Program, a historic effort to gather health data from one million or more people living in the United States. The program aims to accelerate research and improve health by taking into account individual differences in lifestyle, environment, and biology.
Research Contributions[edit]
Rutter's research has focused on the intersection of genetics, environment, and health. She has published numerous studies on the genetic factors that contribute to addiction and the role of pharmacogenomics in personalized medicine.
Pharmacogenomics[edit]
Her work in pharmacogenomics has helped pave the way for more personalized approaches to medicine, where treatments can be tailored to the genetic makeup of individual patients, thereby improving outcomes and reducing adverse effects.
Addiction Genetics[edit]
Rutter has also been a leading figure in the study of addiction genetics, exploring how genetic predispositions can influence the risk of developing substance use disorders. Her research has provided insights into potential targets for therapeutic intervention.
Awards and Honors[edit]
Throughout her career, Joni L. Rutter has received numerous awards and honors for her contributions to medical research and public health. Her work has been recognized by various scientific organizations and institutions.
